Understanding how CXCR4 influences the development of B cells
Role of CXCR4 in immunoglobulin light chain recombination
This study is looking at how a specific signal in the body helps B cells, which are important for fighting infections, grow and develop properly, with the hope that understanding this process can lead to better treatments for autoimmune diseases and cancers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11026365 on NIH RePORTER |
What this research studies
This research investigates the role of CXCR4 in the development of B lymphocytes, which are crucial for the immune response. It focuses on how CXCR4 signaling affects the recombination of immunoglobulin light chains in B cells, a process essential for producing antibodies. By examining the interactions between different cellular signals during B cell development, the study aims to uncover mechanisms that could lead to improved treatments for autoimmune diseases and cancers. Patients may benefit from insights gained into how B cells function and how their development can be manipulated for therapeutic purposes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with autoimmune conditions or cancers related to B cell dysfunction.
Not a fit: Patients with conditions unrelated to B cell development or those who do not have autoimmune diseases or cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating autoimmune diseases and certain cancers by enhancing our understanding of B cell development.
How similar studies have performed: Previous research has shown promising results in understanding B cell development and its implications for treatment, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Clark, Marcus Ramsay — University of Chicago
- Study coordinator: Clark, Marcus Ramsay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.